---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-151942"
form_type: "8-K"
ticker: "IMA"
cik: "0001835579"
company_name: "ImageneBio, Inc."
filed_at: "2026-04-13T23:59:59+00:00"
generated_at: "2026-05-15T06:36:40.294846+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ImageneBio raises ~$30M via pre-funded warrants to fund atopic dermatitis and alopecia areata programs

## Summary
- Gross proceeds of ~$30M from sale of pre-funded warrants for 5.77M shares at $5.199 each.
- Closing expected April 14, 2026; warrants exercisable at $0.001, no expiration.
- Proceeds to fund late-phase development in atopic dermatitis and expand IMG-007 into alopecia areata.
- Registration rights agreement requires filing by early August 2026; cash penalties for delays.
- Beneficial ownership limitation set at 19.99% per investor.

## SEC filing metadata
- accession: 0001193125-26-151942
- form_type: 8-K
- ticker: IMA
- cik: 0001835579
- company_name: ImageneBio, Inc.
- filed_at: 2026-04-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835579/000119312526151942/0001193125-26-151942-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835579/000119312526151942/d143873d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-151942
- JSON: https://secwatch.observer/filing/0001193125-26-151942.json
- Plain text: https://secwatch.observer/filing/0001193125-26-151942.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.